Skip to main navigation
Skip to search
Skip to main content
the University of Groningen research portal Home
Help & FAQ
English
Nederlands
Home
Profiles
Research units
Research output
Activities
Datasets
Press/Media
Projects
Prizes
Search by expertise, name or affiliation
Oncolytic virotherapy - analysis, design, models
Darshak Bhatt
Microbes in Health and Disease (MHD)
Research output
:
Thesis
›
Thesis fully internal (DIV)
908
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Oncolytic virotherapy - analysis, design, models'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Analysis Design
100%
Virotherapy
100%
Design Model
100%
Oncolytic Virus
100%
Oncolytic Virotherapy
100%
Immune Cells
66%
Virus
66%
Tumor Cells
66%
Semliki Forest Virus
66%
Tumor Eradication
66%
Drug-resistant Tumor
66%
Tumor-immune System
66%
Tumor
33%
Infected Cells
33%
Genetic Engineering
33%
Spatiotemporal Dynamics
33%
Clinical Application
33%
Early 20th Century
33%
Immune Response
33%
Immuno
33%
Immunogenic
33%
Immune Activation
33%
Stromal Cells
33%
Highly Effective
33%
Cellular Mechanisms
33%
Anticancer
33%
Oncolytic
33%
Cell Spreading
33%
Co-culture Assay
33%
Clinical Evidence
33%
Inflammatory Molecules
33%
Traceback
33%
T Cell Cytotoxicity
33%
Genetically Modified Viruses
33%
Tumor Stromal Cells
33%
Replicon Particle
33%
Systemic Mechanisms
33%
Computational Modeling Methods
33%
Tumor Immunogenicity
33%
Tumor-derived Extracellular Vesicles
33%
Medicine and Dentistry
Neoplasm
100%
Oncolytic Virotherapy
100%
Infection
66%
Oncolytic Virus
50%
Virotherapy
50%
Tumor Cell
33%
Immunocompetent Cell
33%
Semliki Forest Virus
33%
T Cell
16%
Malignant Neoplasm
16%
Immune Response
16%
Cytokine
16%
Immunoglobulin
16%
Replicon
16%
Cytotoxicity
16%
Cell Spreading
16%
Stromal Cell
16%
Tumor Immunogenicity
16%
Immunology and Microbiology
Virotherapy
100%
Oncolytic Virus
50%
Tumor Cell
33%
Immunocompetent Cell
33%
Semliki Forest Virus
33%
T Cell
16%
Immune Response
16%
Dynamics
16%
Coculture
16%
Cytokine
16%
Intravenous Immunoglobulin
16%
Cytotoxicity
16%
Cell Spreading
16%
Replicon
16%
Tumor Immunogenicity
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Virotherapy
100%
Infection
44%
Oncolytic Virus
33%
Semliki Forest Virus
22%
Malignant Neoplasm
11%
Immunogenicity
11%
Cytokine
11%
Cytotoxicity
11%
Immunoglobulin
11%